Modelling the first dose of measles vaccination: the role of maternal immunity, demographic factors, and delivery systems (Q36588006)

15 August 2017

Modelling the first dose of measles vaccination: the role of maternal immunity, demographic factors, and delivery systems (English)

1 reference

15 August 2017

0 references

0 references

1 reference

P Klepac

2

0 references

C Jessica E Metcalf

1

object named as

C J E Metcalf

1 reference

15 August 2017

M Ferrari

3

1 reference

15 August 2017

R F Grais

4

1 reference

15 August 2017

A Djibo

5

1 reference

15 August 2017

B T Grenfell

6

1 reference

15 August 2017

7 June 2010

1 reference

Epidemiology and Infection

15 August 2017

1 reference

15 August 2017

139

1 reference

15 August 2017

2

1 reference

15 August 2017

265-274

1 reference

Episodic outbreaks bias estimates of age-specific force of infection: a corrected method using measles as an example

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4756473

Scheduling of measles vaccination in low-income countries: projections of a dynamic model

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4756473

Timing of children's vaccinations in 45 low-income and middle-income countries: an analysis of survey data

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4756473

Estimates of measles case fatality ratios: a comprehensive review of community-based studies.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4756473

The dynamics of measles in sub-Saharan Africa

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4756473

Unacceptably high mortality related to measles epidemics in Niger, Nigeria, and Chad

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4756473

A simple model for complex dynamical transitions in epidemics

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4756473

Early two-dose measles vaccination schedule in Guinea-Bissau: good protection and coverage in infancy

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4756473

Two-dose measles vaccination schedules

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4756473

Comparison of immunogenicity and reactogenicity of a measles, mumps and rubella (MMR) vaccine in German children vaccinated at 9-11, 12-14 or 15-17 months of age.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4756473

Response to measles vaccine in Haitian infants 6 to 12 months old. Influence of maternal antibodies, malnutrition, and concurrent illnesses.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4756473

Measles vaccine efficacy in children previously vaccinated at 12 months of age

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4756473

Has the 2005 measles mortality reduction goal been achieved? A natural history modelling study

28 June 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810001329

Immunogenicity and efficacy of one dose measles-mumps-rubella (MMR) vaccine at twelve months of age as compared to monovalent measles vaccination at nine months followed by MMR revaccination at fifteen months of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810001329

Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810001329

Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810001329

Interpreting time-series analyses for continuous-time biological models--measles as a case study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810001329

Stage-structured transmission of phocine distemper virus in the Dutch 2002 outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810001329

The pre-vaccination epidemiology of measles, mumps and rubella in Europe: implications for modelling studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810001329

The modification in measles vaccination age as a consequence of the earlier decline of transplacentally transferred antimeasles antibodies in Turkish infants

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20525415

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Immune response to measles, mumps & rubella vaccine at 9, 12 & 15 months of age

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20525415

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1017/S0950268810001329

1 reference

15 August 2017

1 reference

15 August 2017

1 reference